Praxis Precision Medicines, Inc. (PRAX)
USD 70.12
(-3.96%)
USD 70.12
(-3.96%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -111.13 Million | -185.04 Million | -124.55 Million | -52.62 Million | -33.42 Million | -20.72 Million |
| Net Income | -123.27 Million | -214.02 Million | -167.06 Million | -61.82 Million | -35.51 Million | -26.53 Million |
| Depreciation & Amortization | 432 Thousand | 419 Thousand | 182 Thousand | 50 Thousand | 37 Thousand | 1000.00 |
| Deferred income taxes | 8.85 Million | - | 2.08 Million | - | - | 3.64 Million |
| Stock-based compensation | 24.85 Million | 28.59 Million | 22.69 Million | 5.21 Million | 668 Thousand | 579 Thousand |
| Change in working capital | -14.03 Million | -1.78 Million | 16.13 Million | 3.24 Million | 745 Thousand | 1.45 Million |
| Other non-cash items | -7.97 Million | 1.75 Million | 1.41 Million | 696 Thousand | 642 Thousand | 127 Thousand |
| Investing Cash Flow | 38.95 Million | 96.88 Million | -140.52 Million | 4000.00 | -103 Thousand | -63 Thousand |
| Investments in PPE | -50 Thousand | -444 Thousand | -1.05 Million | 4000.00 | -103 Thousand | -63 Thousand |
| Acquisitions | - | -97.33 Million | 139.47 Million | - | - | - |
| Investment purchases | - | -83.02 Million | -164.17 Million | - | - | - |
| Sales/Maturities of investments | 39 Million | 180.35 Million | 24.7 Million | - | - | - |
| Other Investing Activities | 39 Million | 97.33 Million | -139.47 Million | - | - | - |
| Financing Cash Flow | 91.87 Million | 10.46 Million | 107.58 Million | 304.41 Million | 60.38 Million | 37.8 Million |
| Debt repayment | -1 Million | -811 Thousand | -763 Thousand | -696 Thousand | -633 Thousand | -1 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -137 Thousand | -260 Thousand | - | -30 Million | - | - |
| Common Stock Issuance | 91.59 Million | 9.56 Million | 107.58 Million | 334.41 Million | 60.38 Million | 36.8 Million |
| Other Financing Activities | 1.28 Million | 2.78 Million | 107.58 Million | 304.41 Million | 633 Thousand | 37.8 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -8.85 Million | 3.89 Million | 7.26 Million | 960 Thousand | -837 Thousand | 1.66 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -5.17 Million | -5.67 Million | 8.86 Million | 2.28 Million | 1.58 Million | -208 Thousand |
| Cash at beginning of period | 62.03 Million | 139.72 Million | 297.2 Million | 45.41 Million | 18.55 Million | 1.53 Million |
| Cash at end of period | 81.71 Million | 62.03 Million | 139.72 Million | 297.2 Million | 45.41 Million | 18.55 Million |
| Capital Expenditure | -50 Thousand | -444 Thousand | -1.05 Million | 4000.00 | -103 Thousand | -63 Thousand |
| Effect of forex changes on cash | - | - | - | -4000.00 | - | - |
| Net cash flow / Change in cash | 19.68 Million | -77.68 Million | -157.48 Million | 251.79 Million | 26.86 Million | 17.02 Million |
| Free Cash Flow | -111.18 Million | -185.48 Million | -125.6 Million | -52.61 Million | -33.52 Million | -20.78 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -32.67 Million | -39.55 Million | -26.87 Million | -123.27 Million | -24.63 Million | -34.31 Million |
| Depreciation & Amortization | 107 Thousand | 112 Thousand | 111 Thousand | 432 Thousand | 109 Thousand | 106 Thousand |
| Deferred income taxes | - | - | -2000.00 | 8.85 Million | - | 2000.00 |
| Stock-based compensation | 5.87 Million | 14.47 Million | 5.72 Million | 24.85 Million | 5.76 Million | 5.77 Million |
| Change in working capital | 715 Thousand | 1.46 Million | -3.03 Million | -14.03 Million | -4.66 Million | -2.99 Million |
| Other non-cash items | -1.3 Million | 2.64 Million | 218 Thousand | -7.97 Million | 212 Thousand | 206 Thousand |
| Investing Cash Flow | -195.92 Million | -91.22 Million | -50 Thousand | 38.95 Million | - | 5 Million |
| Investments in PPE | - | - | -50 Thousand | -50 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -198.92 Million | -91.22 Million | - | - | - | - |
| Sales/Maturities of investments | 3 Million | - | - | 39 Million | - | 5 Million |
| Other Investing Activities | - | -91.22 Million | - | 39 Million | - | 5 Million |
| Financing Cash Flow | 216.36 Million | 182.75 Million | 4.12 Million | 91.87 Million | -1000.00 | 69.67 Million |
| Debt repayment | -278 Thousand | -271 Thousand | -261 Thousand | -1 Million | -254 Thousand | -250 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -137 Thousand | -5000.00 | -137 Thousand | -1000.00 | -4000.00 |
| Common Stock Issuance | 216.06 Million | 182.75 Million | 4.02 Million | 91.59 Million | 1000.00 | 69.47 Million |
| Other Financing Activities | 302 Thousand | 6000.00 | 362 Thousand | 1.28 Million | 507 Thousand | 708 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.4 Million | 3.58 Million | -1.29 Million | -8.85 Million | -894 Thousand | -8.97 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.11 Million | -2.12 Million | -1.73 Million | -5.17 Million | -3.77 Million | 5.98 Million |
| Cash at beginning of period | 152.39 Million | 81.71 Million | 101.5 Million | 62.03 Million | 124.71 Million | 81.25 Million |
| Cash at end of period | 145.55 Million | 152.39 Million | 81.71 Million | 81.71 Million | 101.5 Million | 124.71 Million |
| Capital Expenditure | - | - | -50 Thousand | -50 Thousand | - | - |
| Effect of forex changes on cash | - | - | 36.68 Million | - | - | -36.68 Million |
| Net cash flow / Change in cash | -6.83 Million | 70.68 Million | -19.78 Million | 19.68 Million | -23.21 Million | 43.46 Million |
| Free Cash Flow | -27.27 Million | -20.85 Million | -23.91 Million | -111.18 Million | -23.21 Million | -31.21 Million |
PURVA
DGDCF
WSC
2321
LEN
HYBRIDFIN